Insiders · Profile

Schwartz Aharon

Director at Protalix BioTherapeutics. Filing since 7 Apr 2020. CIK 0001625184

Company
Date
Role
Action
Shares
Amount
Of holding
10 Jun 2025
Director
Bought
129,000
$205.88K
74.1%
3 Jan 2023
Director
Bought
110,000
$155.82K
172%
7 Apr 2020
Director
Bought
64,000
$155.26K
opened
3 decisions on file.